Stock Analysis

Ultralife Third Quarter 2022 Earnings: EPS Misses Expectations

  •  Updated
NasdaqGM:ULBI
Source: Shutterstock

Ultralife (NASDAQ:ULBI) Third Quarter 2022 Results

Key Financial Results
  • Revenue: US$33.2m (up 53% from 3Q 2021).
  • Net loss: US$239.0k (loss narrowed by 59% from 3Q 2021).
  • US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021).
earnings-and-revenue-growth
NasdaqGM:ULBI Earnings and Revenue Growth October 28th 2022

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ultralife EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.

Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US.

Performance of the American Electrical industry.

The company's shares are down 15% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Ultralife you should know about.

Valuation is complex, but we're helping make it simple.

Find out whether Ultralife is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis